Patricia D. Pelton
Johnson & Johnson Pharmaceutical Research and Development
LLC, 1000 Route 202
Raritan
USA
Name/email consistency: high
- GW-501516 GlaxoSmithKline/Ligand. Pelton, P. Curr. Opin. Investig. Drugs (2006)
- Nuclear receptors as potential targets for modulating reverse cholesterol transport. Pelton, P.D., Patel, M., Demarest, K.T. Curr. Top. Med. Chem (2005)